Full-Year Revenue Growth and Operating Performance
Consolidated full-year 2025 revenue of $2.8 billion, up 5% year-over-year (fifth consecutive year of revenue growth). Consolidated operating income increased to $305 million, up $58 million or 24% year-over-year. Full-year adjusted EBITDA was $401 million, up $54 million or 16% versus 2024.
Strong Cash Generation and Balance Sheet
Year-end cash balance increased to $689 million, a 38% increase versus the end of 2024. Generated $319 million of cash from operations for the full year (up $116 million), full-year free cash flow of $208 million compared to $96.1 million in 2024 (approximately +116%). Total liquidity of $904 million (cash plus undrawn revolver).
Robust Order Intake and Book-to-Bill
Full-year order intake of $3.7 billion, representing a book-to-bill ratio of 1.33 (up from 1.10 in 2024, ~+21%), indicating healthy demand relative to revenue.
ADTech Growth and Record Contract Win
ADTech revenue increased 29% year-over-year in Q4 2025 and Q4 operating income rose 43% with operating margin improving to 11%. Won the largest initial contract award in company history through the ADTech business and finished 2025 with a strong multiyear backlog supporting future growth.
Subsea Robotics (SSR) Operational Improvements
SSR Q4 operating income of $67.8 million, up 7% year-over-year with EBITDA margins improving to 38% from 36% (200 bps improvement). Achieved 99% ROV uptime for the second consecutive year and improved ROV pricing by 7% year-over-year; average ROV revenue per day increased 7% (from $10,481 to $11,210) with a Q4 exit rate of $11,550.
Safety and Capital Allocation
Record low total recordable incident rate (TRIR) of 0.22 in 2025. Repurchased approximately 1.8 million shares for $40 million during the year, demonstrating shareholder return actions alongside investment in growth.
Manufactured Products Recovery
Full-year Manufactured Products revenue of $569 million and operating income of $72 million — the highest levels since 2020. Q4 operating income margin improved to 15% despite a 7% revenue decline in the quarter due to conversion of high-margin umbilicals backlog and improved non-energy project results.
Q4 Cash and Working Capital Timing Benefit
Q4 2025 generated $221 million of cash from operations and free cash flow of $191 million, benefiting from the timing of customer payments (including early receipt of payments originally due in Q1 2026).